It has been largely demonstrated that SIRT1 is a major target of resveratrol, and several studies demonstrated that SIRT1 upregulation is required for resveratrol-mediated chemopreventive effects in colorectal cancer cells [38,39]. Here, SIRT1 is linked to colorectal cancer.